Articles de revue sur le cancer du rein - Dernières parutions

InTextoResearch, agence d'information scientifique


InTextoResearch vous informe sur les dernières parutions d'articles de
revue sur le cancer du rein (17 novembre 2007):

Targeted therapy in metastatic renal cell carcinoma.
De Mulder PH.
Ann Oncol. 2007 Jul;18 Suppl 9:ix98-102.

Renal cell cancer: is immunotherapy dead?
Wagstaff J.
Ann Oncol. 2007 Jul;18 Suppl 9:ix94-7.

Temsirolimus in the treatment of advanced renal cell carcinoma.
Gore ME.
Ann Oncol. 2007 Jul;18 Suppl 9:ix87-8.

New challenges in kidney cancer therapy: sunitinib.
Izzedine H, Billemont B, Thibault F, Rixe O.
Ann Oncol. 2007 Jul;18 Suppl 9:ix83-6.

Protein kinase inhibitors in the treatment of renal cell carcinoma:
sorafenib.
Bracarda S, Caserta C, Sordini L, Rossi M, Hamzay A, Crinò L.
Ann Oncol. 2007 Jun;18 Suppl 6:vi22-5.

Role of external radiation therapy in urinary cancers.
Parisi S, Troiano M, Corsa P, Raguso A, Cossa S, Piazzolla EE, Munafò
T, Sanpaolo G, Natuno A, Maiello E.
Ann Oncol. 2007 Jun;18 Suppl 6:vi157-61.

Immunotherapy for metastatic renal cell carcinoma: is it a therapeutic
option yet?
Guida M, Colucci G.
Ann Oncol. 2007 Jun;18 Suppl 6:vi149-52.

Integrated therapy of kidney cancer.
Longo R, D'Andrea MR, Sarmiento R, Salerno F, Gasparini G.
Ann Oncol. 2007 Jun;18 Suppl 6:vi141-8.

State-of-the-art surgical management of renal cell carcinoma.
Thiel DD, Winfield HN.
Expert Rev Anticancer Ther. 2007 Sep;7(9):1285-94.

Safety and tolerability of sorafenib in clear-cell renal cell
carcinoma: a Phase III overview.
Hutson TE.
Expert Rev Anticancer Ther. 2007 Sep;7(9):1193-202.

Renal abnormalities and their developmental origin.
Schedl A.
Nat Rev Genet. 2007 Oct;8(10):791-802.

Sunitinib malate for the treatment of metastatic renal cell carcinoma
and gastrointestinal stromal tumors.
Adams VR, Leggas M.
Clin Ther. 2007 Jul;29(7):1338-53.

Part II: Treatment of primary malignant non-Wilms' renal tumours in
children.
Ahmed HU, Arya M, Levitt G, Duffy PG, Sebire NJ, Mushtaq I.
Lancet Oncol. 2007 Sep;8(9):842-8.

Renal cell carcinoma: imaging and therapy.
Bolton DM, Wong P, Lawrentschuk N.
Curr Opin Urol. 2007 Sep;17(5):337-40.

Recent advances in targeted therapy for renal cell carcinoma.
Clark PE.
Curr Opin Urol. 2007 Sep;17(5):331-6.

Robotic approaches to renal cancer.
Murphy D, Dasgupta P.
Curr Opin Urol. 2007 Sep;17(5):327-30.

Prognostic markers in renal cell carcinoma.
Ljungberg B.
Curr Opin Urol. 2007 Sep;17(5):303-8.

Predicting cancer-control outcomes in patients with renal cell
carcinoma.
Karakiewicz PI, Hutterer GC.
Curr Opin Urol. 2007 Sep;17(5):295-302.

Pseudohypoxic pathways in renal cell carcinoma.
Bratslavsky G, Sudarshan S, Neckers L, Linehan WM.
Clin Cancer Res. 2007 Aug 15;13(16):4667-71.

Application of artificial intelligence to the management of urological
cancer.
Abbod MF, Catto JW, Linkens DA, Hamdy FC.
J Urol. 2007 Oct;178(4 Pt 1):1150-6.

Part I: Primary malignant non-Wilms' renal tumours in children.
Ahmed HU, Arya M, Levitt G, Duffy PG, Mushtaq I, Sebire NJ.
Lancet Oncol. 2007 Aug;8(8):730-7.

Surgery insight: advances in techniques for open partial nephrectomy.
Huang WC, Kagiwada MA, Russo P.
Nat Clin Pract Urol. 2007 Aug;4(8):444-50.

Management of patients with upper urinary tract transitional cell
carcinoma.
Raman JD, Scherr DS.
Nat Clin Pract Urol. 2007 Aug;4(8):432-43.

Drug insight: advances in renal cell carcinoma and the role of
targeted therapies.
Larkin JM, Chowdhury S, Gore ME.
Nat Clin Pract Oncol. 2007 Aug;4(8):470-9.

Sorafenib and sunitinib: novel targeted therapies for renal cell
cancer.
Grandinetti CA, Goldspiel BR.
Pharmacotherapy. 2007 Aug;27(8):1125-44.

Imaging in metastatic renal cell carcinoma.
Griffin N, Gore ME, Sohaib SA.
AJR Am J Roentgenol. 2007 Aug;189(2):360-70.

Molecular therapy in urologic oncology.
Froehner M, Hakenberg OW, Wirth MP.
Urol Int. 2007;79(1):1-7.

Sunitinib (Sutent): a novel agent for the treatment of metastatic
renal cell carcinoma.
Chouhan JD, Zamarripa DE, Lai PH, Oramasionwu CU, Grabinski JL.
J Oncol Pharm Pract. 2007 Mar;13(1):5-15.

CCR drug updates: sorafenib and sunitinib in renal cell carcinoma.
Stein MN, Flaherty KT.
Clin Cancer Res. 2007 Jul 1;13(13):3765-70.



(contact pour InTextoResearch: Marc Lacroix, Baelen, Wallonie,
Belgique - scimedweb@mail.com)